Wenjuan Luo
-
- Viral-associated cancers and disorders 6
-
- Lymphoma Diagnosis and Treatment 4
- Cancer Mechanisms and Therapy 3
-
- Angiogenesis and VEGF in Cancer 4
-
- Virus-based gene therapy research 3
-
- Ocular Oncology and Treatments 3
-
- Lung Cancer Treatments and Mutations 3
-
- Corneal Surgery and Treatments 3
- Co-authors
- Yanmin ZhangKatsuyuki AozasaMeng LiangLangchong HeShuai ZhenTetsuya TakakuwaMaria Francisca HamJiaqi Zhang
- Journals
- Biochemical Journal (1 paper)International Journal of Molecular Sciences (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaJapanUnited Kingdom
In The Last Decade
Wenjuan Luo
41 papers receiving 619 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 113
- Oncology 204
- Pathology and Forensic Medicine 113
- Immunology 125
- Molecular Biology 374
Countries citing papers authored by Wenjuan Luo
This map shows the geographic impact of Wenjuan Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjuan Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjuan Luo more than expected).
Fields of papers citing papers by Wenjuan Luo
This network shows the impact of papers produced by Wenjuan Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjuan Luo. The network helps show where Wenjuan Luo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenjuan Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 7 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 11 | |
| 10 | 2023 | 0 | |
| 11 | 2020 | 27 | |
| 12 | 2016 | 2 | |
| 13 | 2016 | 80 | |
| 14 | 2015 | 10 | |
| 15 | Iris Melanoma Features And Prognosis In Children And Adults In 317 Patients | 2012 | 5 |
| 16 | 2011 | 66 | |
| 17 | Construction of a high-EGFR expression cell line and its biological properties comparing with A431 cell | 2010 | 11 |
| 18 | 2004 | 28 | |
| 19 | 2003 | 37 | |
| 20 | 2002 | 6 |
About Wenjuan Luo
Wenjuan Luo is a scholar working on Discrete Mathematics and Combinatorics, Oncology and Ophthalmology, having authored 49 papers that have together received 629 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (6 papers), Angiogenesis and VEGF in Cancer (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Virus-based gene therapy research (3 papers), Ocular Oncology and Treatments (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer Mechanisms and Therapy (3 papers) and Corneal Surgery and Treatments (3 papers). The work is most often cited by research in Cancer Research (113 citations), Oncology (204 citations) and Pathology and Forensic Medicine (113 citations). Wenjuan Luo has collaborated with scholars based in China, Japan and United Kingdom. Frequent co-authors include Yanmin Zhang, Katsuyuki Aozasa, Meng Liang, Langchong He, Shuai Zhen, Tetsuya Takakuwa, Maria Francisca Ham, Jiaqi Zhang, Xiaomin Sun and Xu Li. Their work appears in journals such as Biochemical Journal, International Journal of Molecular Sciences and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.